Acute Coronary Syndrome III: Diagnostic Studies

A detailed patient history focuses on chest pain characteristics, previous cardiac history, and family history of heart disease. Risk factors including obesity, smoking, and hyperlipidemia must be assessed. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating, nausea, vomiting, dizziness, and palpitations.

A 12-lead ECG should be performed within 10 minutes of patient presentation to identify critical changes such as ST elevation indicating STEMI, ST depression and T-wave inversion suggesting NSTEMI, and abnormal Q waves from necrosis. Rapid identification of these changes significantly impacts timely initiation of life-saving treatments, reducing severe complications and improving patient outcomes.

Cardiac biomarkers appear in the blood when the heart is injured due to inadequate oxygen. Troponins I and T are the most reliable indicators, appearing within 3-6 hours and remaining elevated for up to two weeks. Creatine kinase-MB appears in 3-6 hours, while myoglobin rises in 1-3 hours but lacks specificity, making troponins the primary diagnostic tool recommended by the American Heart Association.

Physical examination may reveal jugular venous distention and peripheral edema indicating heart failure. Auscultation may detect new murmurs suggesting mitral regurgitation or ventricular septal defect. Respiratory examination assesses for rales or crackles indicating pulmonary congestion. These findings combined with vital sign abnormalities help confirm acute coronary syndrome complications.

Echocardiography evaluates left ventricular function and detects hypokinetic and akinetic wall motion abnormalities. It is particularly useful when ECG findings are inconclusive and helps determine ejection fraction. This imaging study provides critical information about cardiac function and structural changes resulting from myocardial injury.

Coronary angiography is the definitive diagnostic tool for locating and evaluating the severity of coronary artery blockages. Unlike echocardiography or chest X-ray, it directly visualizes arterial blockages and guides revascularization strategies. This invasive procedure provides the most specific information about coronary artery disease and treatment options.

Beyond cardiac biomarkers, complete blood count assesses for anemia or infection, lipid profile evaluates cardiovascular risk, blood glucose and HbA1c identify diabetes, and renal function tests assess kidney status prior to certain treatments. These tests help evaluate overall cardiovascular risk factors and guide treatment decisions in acute coronary syndrome management.